David Ajayi, a Nigerian-born data science leader, is redefining clinical research infrastructure and digital health systems ...

The symptoms can include nerve pain, emotional numbness and sexual dysfunction and can last for years after stopping the ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Eli Lilly announced an update on its Phase 3 clinical study testing Mirikizumab for pediatric Crohn’s disease, showing real ...

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...

President Donald Trump said he planned to implement a 50% duty on copper imports as part of a set of looming sectoral tariffs ...

Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...

The stocks listed here each increased their dividend payments by more than 10% recently. When you think of a great dividend ...

In a new consensus statement, the European Society of Cardiology has declared vaccinations for common infections to be a ...

A Reuters review found that just under half of the claimed spending on the website originated under Joe Biden or represented ...

Eli Lilly and Johnson & Johnson, PPH’s largest holdings, are facing unique challenges, impacting the ETF’s overall ...

Prime Medicine, Inc. achieved strong early data in CGD with PM359, surpassing efficacy thresholds. Click here to find out why ...